-
Building Efficient and Effective OpenQA Systems for Low-Resource Languages
Authors:
Emrah Budur,
Rıza Özçelik,
Dilara Soylu,
Omar Khattab,
Tunga Güngör,
Christopher Potts
Abstract:
Question answering (QA) is the task of answering questions posed in natural language with free-form natural language answers extracted from a given passage. In the OpenQA variant, only a question text is given, and the system must retrieve relevant passages from an unstructured knowledge source and use them to provide answers, which is the case in the mainstream QA systems on the Web. QA systems c…
▽ More
Question answering (QA) is the task of answering questions posed in natural language with free-form natural language answers extracted from a given passage. In the OpenQA variant, only a question text is given, and the system must retrieve relevant passages from an unstructured knowledge source and use them to provide answers, which is the case in the mainstream QA systems on the Web. QA systems currently are mostly limited to the English language due to the lack of large-scale labeled QA datasets in non-English languages. In this paper, we show that effective, low-cost OpenQA systems can be developed for low-resource contexts. The key ingredients are (1) weak supervision using machine-translated labeled datasets and (2) a relevant unstructured knowledge source in the target language context. Furthermore, we show that only a few hundred gold assessment examples are needed to reliably evaluate these systems. We apply our method to Turkish as a challenging case study, since English and Turkish are typologically very distinct and Turkish has limited resources for QA. We present SQuAD-TR, a machine translation of SQuAD2.0, and we build our OpenQA system by adapting ColBERT-QA and retraining it over Turkish resources and SQuAD-TR using two versions of Wikipedia dumps spanning two years. We obtain a performance improvement of 24-32% in the Exact Match (EM) score and 22-29% in the F1 score compared to the BM25-based and DPR-based baseline QA reader models. Our results show that SQuAD-TR makes OpenQA feasible for Turkish, which we hope encourages researchers to build OpenQA systems in other low-resource languages. We make all the code, models, and the dataset publicly available at https://github.com/boun-tabi/SQuAD-TR.
△ Less
Submitted 4 June, 2024; v1 submitted 7 January, 2024;
originally announced January 2024.
-
Structure-based drug discovery with deep learning
Authors:
Rıza Özçelik,
Derek van Tilborg,
José Jiménez-Luna,
Francesca Grisoni
Abstract:
Artificial intelligence (AI) in the form of deep learning bears promise for drug discovery and chemical biology, $\textit{e.g.}$, to predict protein structure and molecular bioactivity, plan organic synthesis, and design molecules $\textit{de novo}$. While most of the deep learning efforts in drug discovery have focused on ligand-based approaches, structure-based drug discovery has the potential t…
▽ More
Artificial intelligence (AI) in the form of deep learning bears promise for drug discovery and chemical biology, $\textit{e.g.}$, to predict protein structure and molecular bioactivity, plan organic synthesis, and design molecules $\textit{de novo}$. While most of the deep learning efforts in drug discovery have focused on ligand-based approaches, structure-based drug discovery has the potential to tackle unsolved challenges, such as affinity prediction for unexplored protein targets, binding-mechanism elucidation, and the rationalization of related chemical kinetic properties. Advances in deep learning methodologies and the availability of accurate predictions for protein tertiary structure advocate for a $\textit{renaissance}$ in structure-based approaches for drug discovery guided by AI. This review summarizes the most prominent algorithmic concepts in structure-based deep learning for drug discovery, and forecasts opportunities, applications, and challenges ahead.
△ Less
Submitted 26 December, 2022;
originally announced December 2022.
-
Exploring Data-Driven Chemical SMILES Tokenization Approaches to Identify Key Protein-Ligand Binding Moieties
Authors:
Asu Büşra Temizer,
Gökçe Uludoğan,
Rıza Özçelik,
Taha Koulani,
Elif Ozkirimli,
Kutlu O. Ulgen,
Nilgün Karalı,
Arzucan Özgür
Abstract:
Machine learning models have found numerous successful applications in computational drug discovery. A large body of these models represents molecules as sequences since molecular sequences are easily available, simple, and informative. The sequence-based models often segment molecular sequences into pieces called chemical words (analogous to the words that make up sentences in human languages) an…
▽ More
Machine learning models have found numerous successful applications in computational drug discovery. A large body of these models represents molecules as sequences since molecular sequences are easily available, simple, and informative. The sequence-based models often segment molecular sequences into pieces called chemical words (analogous to the words that make up sentences in human languages) and then apply advanced natural language processing techniques for tasks such as $\textit{de novo}$ drug design, property prediction, and binding affinity prediction. However, the chemical characteristics and significance of these building blocks, chemical words, remain unexplored. This study aims to investigate the chemical vocabularies generated by popular subword tokenization algorithms, namely Byte Pair Encoding (BPE), WordPiece, and Unigram, and identify key chemical words associated with protein-ligand binding. To this end, we build a language-inspired pipeline that treats high affinity ligands of protein targets as documents and selects key chemical words making up those ligands based on tf-idf weighting. Further, we conduct case studies on a number of protein families to analyze the impact of key chemical words on binding. Through our analysis, we find that these key chemical words are specific to protein targets and correspond to known pharmacophores and functional groups. Our findings will help shed light on the chemistry captured by the chemical words, and by machine learning models for drug discovery at large.
△ Less
Submitted 25 September, 2023; v1 submitted 26 October, 2022;
originally announced October 2022.
-
DebiasedDTA: A Framework for Improving the Generalizability of Drug-Target Affinity Prediction Models
Authors:
Rıza Özçelik,
Alperen Bağ,
Berk Atıl,
Melih Barsbey,
Arzucan Özgür,
Elif Özkırımlı
Abstract:
Computational models that accurately predict the binding affinity of an input protein-chemical pair can accelerate drug discovery studies. These models are trained on available protein-chemical interaction datasets, which may contain dataset biases that may lead the model to learn dataset-specific patterns, instead of generalizable relationships. As a result, the prediction performance of models d…
▽ More
Computational models that accurately predict the binding affinity of an input protein-chemical pair can accelerate drug discovery studies. These models are trained on available protein-chemical interaction datasets, which may contain dataset biases that may lead the model to learn dataset-specific patterns, instead of generalizable relationships. As a result, the prediction performance of models drops for previously unseen biomolecules, $\textit{i.e.}$ the prediction models cannot generalize to biomolecules outside of the dataset. The latest approaches that aim to improve model generalizability either have limited applicability or introduce the risk of degrading prediction performance. Here, we present DebiasedDTA, a novel drug-target affinity (DTA) prediction model training framework that addresses dataset biases to improve the generalizability of affinity prediction models. DebiasedDTA reweights the training samples to mitigate the effect of dataset biases and is applicable to most DTA prediction models. The results suggest that models trained in the DebiasedDTA framework can achieve improved generalizability in predicting the interactions of the previously unseen biomolecules, as well as performance improvements on those previously seen. Extensive experiments with different biomolecule representations, model architectures, and datasets demonstrate that DebiasedDTA can upgrade DTA prediction models irrespective of the biomolecule representation, model architecture, and training dataset. Last but not least, we release DebiasedDTA as an open-source python library to enable other researchers to debias their own predictors and/or develop their own debiasing methods. We believe that this python library will corroborate and foster research to develop more generalizable DTA prediction models.
△ Less
Submitted 8 January, 2023; v1 submitted 4 July, 2021;
originally announced July 2021.
-
Vapur: A Search Engine to Find Related Protein-Compound Pairs in COVID-19 Literature
Authors:
Abdullatif Köksal,
Hilal Dönmez,
Rıza Özçelik,
Elif Ozkirimli,
Arzucan Özgür
Abstract:
Coronavirus Disease of 2019 (COVID-19) created dire consequences globally and triggered an intense scientific effort from different domains. The resulting publications created a huge text collection in which finding the studies related to a biomolecule of interest is challenging for general purpose search engines because the publications are rich in domain specific terminology. Here, we present Va…
▽ More
Coronavirus Disease of 2019 (COVID-19) created dire consequences globally and triggered an intense scientific effort from different domains. The resulting publications created a huge text collection in which finding the studies related to a biomolecule of interest is challenging for general purpose search engines because the publications are rich in domain specific terminology. Here, we present Vapur: an online COVID-19 search engine specifically designed to find related protein - chemical pairs. Vapur is empowered with a relation-oriented inverted index that is able to retrieve and group studies for a query biomolecule with respect to its related entities. The inverted index of Vapur is automatically created with a BioNLP pipeline and integrated with an online user interface. The online interface is designed for the smooth traversal of the current literature by domain researchers and is publicly available at https://tabilab.cmpe.boun.edu.tr/vapur/ .
△ Less
Submitted 13 October, 2020; v1 submitted 5 September, 2020;
originally announced September 2020.
-
Data and Representation for Turkish Natural Language Inference
Authors:
Emrah Budur,
Rıza Özçelik,
Tunga Güngör,
Christopher Potts
Abstract:
Large annotated datasets in NLP are overwhelmingly in English. This is an obstacle to progress in other languages. Unfortunately, obtaining new annotated resources for each task in each language would be prohibitively expensive. At the same time, commercial machine translation systems are now robust. Can we leverage these systems to translate English-language datasets automatically? In this paper,…
▽ More
Large annotated datasets in NLP are overwhelmingly in English. This is an obstacle to progress in other languages. Unfortunately, obtaining new annotated resources for each task in each language would be prohibitively expensive. At the same time, commercial machine translation systems are now robust. Can we leverage these systems to translate English-language datasets automatically? In this paper, we offer a positive response for natural language inference (NLI) in Turkish. We translated two large English NLI datasets into Turkish and had a team of experts validate their translation quality and fidelity to the original labels. Using these datasets, we address core issues of representation for Turkish NLI. We find that in-language embeddings are essential and that morphological parsing can be avoided where the training set is large. Finally, we show that models trained on our machine-translated datasets are successful on human-translated evaluation sets. We share all code, models, and data publicly.
△ Less
Submitted 20 October, 2020; v1 submitted 30 April, 2020;
originally announced April 2020.
-
ChemBoost: A chemical language based approach for protein-ligand binding affinity prediction
Authors:
Rıza Özçelik,
Hakime Öztürk,
Arzucan Özgür,
Elif Ozkirimli
Abstract:
Identification of high affinity drug-target interactions is a major research question in drug discovery. Proteins are generally represented by their structures or sequences. However, structures are available only for a small subset of biomolecules and sequence similarity is not always correlated with functional similarity. We propose ChemBoost, a chemical language based approach for affinity predi…
▽ More
Identification of high affinity drug-target interactions is a major research question in drug discovery. Proteins are generally represented by their structures or sequences. However, structures are available only for a small subset of biomolecules and sequence similarity is not always correlated with functional similarity. We propose ChemBoost, a chemical language based approach for affinity prediction using SMILES syntax. We hypothesize that SMILES is a codified language and ligands are documents composed of chemical words. These documents can be used to learn chemical word vectors that represent words in similar contexts with similar vectors. In ChemBoost, the ligands are represented via chemical word embeddings, while the proteins are represented through sequence-based features and/or chemical words of their ligands. Our aim is to process the patterns in SMILES as a language to predict protein-ligand affinity, even when we cannot infer the function from the sequence. We used eXtreme Gradient Boosting to predict protein-ligand affinities in KIBA and BindingDB data sets. ChemBoost was able to predict drug-target binding affinity as well as or better than state-of-the-art machine learning systems. When powered with ligand-centric representations, ChemBoost was more robust to the changes in protein sequence similarity and successfully captured the interactions between a protein and a ligand, even if the protein has low sequence similarity to the known targets of the ligand.
△ Less
Submitted 18 December, 2020; v1 submitted 2 November, 2018;
originally announced November 2018.
